Intrepid Therapeutics, Inc. Report issue

For profit Phase 2
Founded: San Diego CA United States (2010)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2012
NCT01631474
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

clascoterone (Winlevi) (3 trials)

minoxidil (loniten) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Alopecia (Phase 2)

Alopecia Areata (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2